C07D 285/26
Substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
Official title: substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
C07D285/26 (Substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals) appears on 32 US grants and 22 published applications in this corpus.
Search patents in C07D- Granted patents
- 32
- Published applications
- 22
- Assignees
- 24
- Inventors
- 111
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 2 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 0 |
| 2008 | 1 | 3 |
| 2009 | 2 | 2 |
| 2010 | 2 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 3 |
| 2017 | 3 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 2 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX211 Mar 2025US 12,247,015 B2Solent Therapeutics, LLC
- Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,937 B2Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,938 B2Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,939 B2Theaprin Pharmaceuticals Inc.
- 3-amino-4h-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of mrgx218 Sep 2025US 2025/0289792 A1Solent Therapeutics, LLC
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- 3-amino-4h-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of mrgx221 Apr 2022US 2022/0119361 A1Solent Therapeutics, LLC
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jun 2021US 2021/0177758 A1Theaprin Pharmaceuticals Inc.
- Cocrystal of Telmisartan and Hydrochlorothiazide11 Jun 2020US 2020/0181121 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Most cited
By later US patents
- Carboxyalkyl dipeptides as antiglaucoma agents19US 4,616,012 ASchering Corporation · 1986
- Nitric oxide enhancing diuretic compounds, compositions and methods of use19US 7,396,829 B2NitroMed, Inc. · 2008
- Antihypertensive benzothiadiazines18US 4,468,396 ASchering Corporation · 1984
- Nitric oxide donating diuretic compounds, compositions and methods of use17US 7,595,313 B2Nicox S A. · 2009
- Compounds and their use as positive AMPA receptor modulators14US 6,943,159 B1NeuroSearch A/S · 2005